Greenwood Capital Associates LLC Buys New Position in Astera Labs, Inc. $ALAB

Greenwood Capital Associates LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 4,834 shares of the company’s stock, valued at approximately $437,000.

Several other large investors also recently bought and sold shares of ALAB. FengHe Fund Management Pte. Ltd. acquired a new position in shares of Astera Labs in the 2nd quarter valued at approximately $106,772,000. Robeco Institutional Asset Management B.V. bought a new stake in shares of Astera Labs in the second quarter worth $2,996,000. Trilogy Capital Inc. bought a new stake in shares of Astera Labs in the second quarter worth $371,000. Pacific Point Advisors LLC grew its holdings in Astera Labs by 42.9% during the 2nd quarter. Pacific Point Advisors LLC now owns 10,000 shares of the company’s stock worth $904,000 after acquiring an additional 3,000 shares in the last quarter. Finally, PFG Investments LLC acquired a new position in Astera Labs during the 2nd quarter worth $238,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total value of $1,921,600.00. Following the completion of the sale, the general counsel directly owned 151,573 shares of the company’s stock, valued at approximately $29,126,267.68. This represents a 6.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the sale, the director owned 385,863 shares in the company, valued at $66,858,482.01. The trade was a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,492,036 shares of company stock worth $232,607,552 in the last ninety days. Insiders own 12.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on ALAB shares. Jefferies Financial Group increased their price target on shares of Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, July 22nd. Zacks Research upgraded Astera Labs to a “strong-buy” rating in a research note on Tuesday, August 12th. Cowen initiated coverage on Astera Labs in a report on Tuesday. They issued a “hold” rating for the company. Susquehanna raised their price target on shares of Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a research report on Thursday, August 7th. Finally, Barclays restated an “overweight” rating and set a $155.00 price objective (up previously from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $159.83.

Astera Labs Stock Down 4.2%

Shares of ALAB opened at $200.74 on Friday. The firm has a 50-day moving average price of $189.83 and a 200 day moving average price of $119.14. The firm has a market capitalization of $33.37 billion, a PE ratio of 358.46, a P/E/G ratio of 5.32 and a beta of 1.43. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same period in the prior year, the business posted $0.13 EPS. The business’s revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.